GERN Latest Press Releases

-- October 28, 2026 --

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis Globe Newswire 8:00 AM

-- October 21, 2026 --

Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026 Globe Newswire 8:00 AM

-- October 19, 2026 --

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- October 13, 2026 --

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 2:52 PM

-- October 12, 2026 --

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN Business Wire 12:14 PM

Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia Globe Newswire 8:03 AM

-- September 25, 2026 --

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 10:36 PM

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN PRNewswire 10:00 PM

-- September 18, 2026 --

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- September 14, 2026 --

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN Business Wire 2:16 PM

-- September 2, 2026 --

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 3:59 PM

Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm PRNewswire 1:37 PM

Geron to Present at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 18, 2026 --

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- August 5, 2026 --

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 7:00 AM

-- July 22, 2026 --

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026 Globe Newswire 7:00 AM

-- July 15, 2026 --

Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman Globe Newswire 9:00 AM

-- July 14, 2026 --

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:26 PM

-- July 13, 2026 --

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer Globe Newswire 8:00 AM

-- June 18, 2026 --

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes